Metabolic Reserve of the Heart: The Forgotten Link Between Contraction and Coronary Flow

Progress in Cardiovascular Diseases

Volumn 51, Issue 1, 2008, Pages 74-88

  Kassiotis, Christos ^a   Rajabi, Mitra ^a   Taegtmeyer, Heinrich ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; FATTY ACID; GLUCOSE; GLYCOGEN; KETONE; LACTIC ACID; TRIACYLGLYCEROL;

AEROBIC METABOLISM; ARTICLE; ATROPHY; BIOCHEMISTRY; CORONARY ARTERY BLOOD FLOW; DIABETES MELLITUS; ENERGY; EXERCISE; HEART CONTRACTION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; INOTROPISM; MALADJUSTMENT; METABOLISM; OXIDATION; STARVATION; WORKLOAD;

CORONARY CIRCULATION; ENERGY METABOLISM; GLYCOGEN; HUMANS; MYOCARDIAL CONTRACTION; MYOCARDIUM;

EID: 46849089267     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.11.005     Document Type: Article

References (132)

1. Sonnenblick E.H., and Stam Jr. A.C. Cardiac muscle: activation and contraction. Annu Rev Physiol 31 (1969) 647-674
2. Stam Jr. A.C., Weglicki W.B., Feldman J.C., et al. Canine myocardial sarcolemma: its preparation and enzymic activity. J Mol Cell Cardiol 1 (1970) 117-130
3. Sonneblick E.H., Ross Jr. J., and Braunwald E. Oxygen consumption of the heart. Newer concepts of its multifactoral determination. Am J Cardiol 22 (1968) 328-336
4. Sonneblick E.H., Parmley W., and Parmley C.W. The contractile state of the heart as expressed by force-velocity relations. Am J Cardiol 23 (1969) 488-503
5. Sonnenblick E.H. Force-velocity relations in mammalian heart muscle. Am J Physiol 202 (1962) 931-939
6. Ross Jr. J., Covell J.W., Sonnenblick E.H., et al. Contractile state of the heart characterized by force-velocity relations in variably afterloaded and isovolumic beats. Circ Res 18 (1965) 149-163
7. Spann Jr. J.F., Buccino R.A., Sonnenblick E.H., et al. Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy and heart failure. Circ Res 21 (1967) 341-354
8. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Probl Cardiol 19 (1994) 57-116
9. Cohn P.F. Evaluation of inotropic contractile reserve in ischemic heart disease using postextrasystolic potentiation. Circulation 61 (1980) 1071-1075
10. Bonow R.O. Contractile reserve and coronary blood flow reserve in collateral-dependent myocardium. J Am Coll Cardiol 33 (1999) 705-707
11. Gould K.L., Kirkeeide R.L., and Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 15 (1990) 459-474
12. Galatro K., and Chaudhry F.A. Prognostic implications of myocardial contractile reserve in patients with ischemic cardiomyopathy. Echocardiography 17 (2000) 61-67
13. Taegtmeyer H., Golfman L., Sharma S., et al. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann N Y Acad Sci 1015 (2004) 202-213
14. Newsholme EA, Leech L, Duester G: Fuel management. In: Keep on running: the science of training and performance. pp. 95-112. West Sussex, UK: John Wiley & Sons, Ltd., 1994 pp. 95-11.
15. Duffield R., Dawson B., and Goodman C. Energy system contribution to 100-m and 200-m track running events. J Sci Med Sport 7 (2004) 302-313
16. Johansen L., and Quistorff B. 31P-MRS characterization of sprint and endurance trained athletes. Int J Sports Med 24 (2003) 183-189
17. Newsholme E., Leech L., and Duester G. Filling the fuel tanks. In: Keep on running: the science of training and performance (1994), John Wiley & Sons, Ltd., West Sussex, UK 70-94
18. Krebs E.G., and Fischer E.H. The phosphorylase b to a converting enzyme of rabbit skeletal muscle. Biochim Biophys Acta 20 (1956) 150-157
19. Korvald C., Elvenes O.P., and Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 278 (2000) H1345-H1351
20. Callow M., Morton A., and Guppy M. Marathon fatigue: the role of plasma fatty acids, muscle glycogen and blood glucose. Eur J Appl Physiol Occup Physiol 55 (1986) 654-661
21. Sjodin B., and Svedenhag J. Applied physiology of marathon running. Sports Med 2 (1985) 83-99
22. van der Vusse G.J., Janssen G.M., Coumans W.A., et al. Effect of training and 15-, 25-, and 42-km contests on the skeletal muscle content of adenine and guanine nucleotides, creatine phosphate, and glycogen. Int J Sports Med 3 10 Suppl (1989) S146-S152
23. Sherman W.M., Costill D.L., Fink W.J., et al. Effect of a 42.2-km footrace and subsequent rest or exercise on muscle glycogen and enzymes. J Appl Physiol 55 (1983) 1219-1224
24. Borsheim E., and Bahr R. Effect of exercise intensity, duration and mode on post-exercise oxygen consumption. Sports Med 33 (2003) 1037-1060
25. Maehlum S., Grandmontagne M., Newsholme E.A., et al. Magnitude and duration of excess postexercise oxygen consumption in healthy young subjects. Metabolism 35 (1986) 425-429
26. Ren J.M., Semenkovich C.F., Gulve E.A., et al. Exercise induces rapid increases in GLUT4 expression, glucose transport capacity, and insulin-stimulated glycogen storage in muscle. J Biol Chem 269 (1994) 14396-14401
27. Host H.H., Hansen P.A., Nolte L.A., et al. Glycogen supercompensation masks the effect of a training-induced increase in GLUT-4 on muscle glucose transport. J Appl Physiol 85 (1998) 133-138
28. Garcia-Roves P.M., Han D.H., Song Z., et al. Prevention of glycogen supercompensation prolongs the increase in muscle GLUT4 after exercise. Am J Physiol Endocrinol Metab 285 (2003) E729-E736
29. Pilegaard H., Keller C., Steensberg A., et al. Influence of pre-exercise muscle glycogen content on exercise-induced transcriptional regulation of metabolic genes. J Physiol 541 (2002) 261-271
30. Arany Z., He H., Lin J., et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1 (2005) 259-271
31. Pilegaard H., Osada T., Andersen L.T., et al. Substrate availability and transcriptional regulation of metabolic genes in human skeletal muscle during recovery from exercise. Metabolism 54 (2005) 1048-1055
32. Johnson R., Walton J., Krebs H., et al. Metabolic fuels during and after severe exercise in athletes and non-athletes. Lancet 2 (1969) 452-455
33. Brandt J.M., Djouadi F., and Kelly D.P. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 273 (1998) 23786-23792
34. Finck B.N., and Kelly D.P. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation 115 (2007) 2540-2548
35. Henriksen E.J., and Dokken B.B. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Curr Drug Targets 7 (2006) 1435-1441
36. Dokken B.B., and Henriksen E.J. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats. Am J Physiol Endocrinol Metab 291 (2006) E207-E213
37. Henriksen E.J., Kinnick T.R., Teachey M.K., et al. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 284 (2003) E892-E900
38. Sebastian D., Herrero L., Serra D., et al. Carnitine palmitoyltransferase I (Cpt I) overexpression protects L6e9 muscle cells from fatty acid-induced insulin resistance. Am J Physiol Endocrinol Metab (2006)
39. Perdomo G., Commerford S.R., Richard A.M., et al. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem 279 (2004) 27177-27186
40. Fujii N., Jessen N., and Goodyear L.J. AMP-activated protein kinase and the regulation of glucose transport. Am J Physiol Endocrinol Metab 291 (2006) E867-E877
41. Kemppainen J., Tsuchida H., Stolen K., et al. Insulin signalling and resistance in patients with chronic heart failure. J Physiol 550 (2003) 305-315
42. Paternostro G., Camici P.G., Lammertsma A.A., et al. Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest 98 (1996) 2094-2099
43. Dutka D.P., Pitt M., Pagano D., et al. Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease. J Am Coll Cardiol 48 (2006) 2225-2231
44. Iozzo P., Chareonthaitawee P., Dutka D., et al. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 51 (2002) 3020-3024
45. Racker E. Energy cycles in health and disease. Curr Top Cell Regul 18 (1981) 361-375
46. Goodwin G.W., Taylor C.S., and Taegtmeyer H. Regulation of energy metabolism of the heart during acute increase in heart work. J Biol Chem 273 (1998) 29530-29539
47. Taegtmeyer H. Glycogen in the heart-an expanded view. J Mol Cell Cardiol 37 (2004) 7-10
48. Goodwin G.W., and Taegtmeyer H. Improved energy homeostasis of the heart in the metabolic state of exercise. Am J Physiol Heart Circ Physiol 279 (2000) H1490-H1501
49. Nikoulina S.E., Ciaraldi T.P., Mudaliar S., et al. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51 (2002) 2190-2198
50. Sakamoto K., Arnolds D.E., Ekberg I., et al. Exercise regulates Akt and glycogen synthase kinase-3 activities in human skeletal muscle. Biochem Biophys Res Commun 319 (2004) 419-425
51. Sakamoto K., Aschenbach W.G., Hirshman M.F., et al. Akt signaling in skeletal muscle: regulation by exercise and passive stretch. Am J Physiol Endocrinol Metab 285 (2003) E1081-E1088
52. Condorelli G., Drusco A., Stassi G., et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 99 (2002) 12333-12338
53. Horowitz J.F., Leone T.C., Feng W., et al. Effect of endurance training on lipid metabolism in women: a potential role for PPARalpha in the metabolic response to training. Am J Physiol Endocrinol Metab 279 (2000) E348-E355
54. Baar K., Wende A.R., Jones T.E., et al. Adaptations of skeletal muscle to exercise: rapid increase in the transcriptional coactivator PGC-1. FASEB J 16 (2002) 1879-1886
55. Pilegaard H., Saltin B., and Neufer P.D. Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol 546 (2003) 851-858
56. Lehman J.J., Barger P.M., Kovacs A., et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106 (2000) 847-856
57. Fisher D.J., Heymann M.A., and Rudolph A.M. Myocardial oxygen and carbohydrate consumption in fetal lambs in utero and in adult sheep. Am J Physiol 238 (1980) H399-H405
58. Bartelds B., Knoester H., Smid G.B., et al. Perinatal changes in myocardial metabolism in lambs. Circulation 102 (2000) 926-931
59. Navaratnam V. Heart muscle: ultrastructural studies (1987), Cambridge University Press, New York
60. Rolph T., Jones C., and Parry D. Ultrastructural and enzymatic development of fetal guinea pig heart. Am J Physiol 243 (1982) H87-H93
61. Fisher D., Heymann M., and Rudolph A. Myocardial consumption of oxygen and carbohydrates in newborn sheep. Pediatr Res 15 (1981) 843-846
62. Pederson B.A., Chen H., Schroeder J.M., et al. Abnormal cardiac development in the absence of heart glycogen. Mol Cell Biol 24 (2004) 7179-7187
63. Lopaschuk G.D., Spafford M.A., and Marsh D.R. Glycolysis is predominant source of ATP production immediately after birth. Am J Physiol 261 (1991) H1698-H1705
64. Lehman J.J., and Kelly D.P. Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin Exp Pharmacol Physiol 29 (2002) 339-345
65. Onay-Besikci A., Campbell F.M., Hopkins T.A., et al. Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart. Am J Physiol Heart Circ Physiol 284 (2003) H283-H289
66. Sack M.N., Disch D.L., Rockman H.A., et al. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci U S A 94 (1997) 6438-6443
67. Depre C., Shipley G.L., Chen W., et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat Med 4 (1998) 1269-1275
68. Razeghi P., Young M.E., Alcorn J.L., et al. Metabolic gene expression in fetal and failing human heart. Circulation 104 (2001) 2923-2931
69. Taegtmeyer H., and Overturf M.L. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 11 (1988) 416-426
70. Barger P.M., and Kelly D.P. PPAR signaling in the control of cardiac energy metabolism. Trends Cardiovasc Med 10 (2000) 238-245
71. Finck B.N., and Kelly D.P. Peroxisome proliferator-activated receptor alpha (PPARalpha) signaling in the gene regulatory control of energy metabolism in the normal and diseased heart. J Mol Cell Cardiol 34 (2002) 1249-1257
72. Finck B.N., and Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116 (2006) 615-622
73. Barger P.M., Brandt J.M., Leone T.C., et al. Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth. J Clin Invest 105 (2000) 1723-1730
74. Disch D.L., Rader T.A., Cresci S., et al. Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression. Mol Cell Biol 16 (1996) 4043-4051
75. Latronico M.V., Costinean S., Lavitrano M.L., et al. Regulation of cell size and contractile function by AKT in cardiomyocytes. Ann N Y Acad Sci 1015 (2004) 250-260
76. Badorff C., Ruetten H., Mueller S., et al. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest 109 (2002) 373-381
77. Haq S., Choukroun G., Kang Z.B., et al. Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy. J Cell Biol 151 (2000) 117-130
78. Michael A., Haq S., Chen X., et al. Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart. J Biol Chem 279 (2004) 21383-21393
79. Matsui T., Tao J., del Monte F., et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104 (2001) 330-335
80. Lawrence J.C., and Roach P.J. New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes 46 (1997) 541-547
81. Luptak I., Balschi J.A., Xing Y., et al. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization. Circulation 112 (2005) 2339-2346
82. Matsui T., Li L., Wu J., et al. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem 277 (2002) 22896-22901
83. Holubarsch C., Goulette R.P., Litten R.Z., et al. The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium. Circ Res 56 (1985) 78-86
84. Young M.E., McNulty P., and Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation 105 (2002) 1861-1870
85. Young M.E., Yan J., Razeghi P., et al. Proposed regulation of gene expression by glucose in rodent heart. Gene Reg Sys Biol 1 (2007) 251-262
86. Young M.E., Laws F.A., Goodwin G.W., et al. Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart. J Biol Chem 276 (2001) 44390-44395
87. Wambolt R.B., Henning S.L., English D.R., et al. Regression of cardiac hypertrophy normalizes glucose metabolism and left ventricular function during reperfusion. J Mol Cell Cardiol 29 (1997) 939-948
88. Razeghi P., Young M.E., Ying J., et al. Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading. Cardiology 97 (2002) 203-209
89. Sharma S., Ying J., Razeghi P., et al. Atrophic remodeling of the transplanted rat heart. Cardiology 105 (2006) 128-136
90. Semenza G.L., Agani F., Iyer N., et al. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann N Y Acad Sci 30 (1999) 262-268
91. Huss J.M., Levy F.H., and Kelly D.P. Hypoxia inhibits the PPAR{alpha}/RXR gene regulatory pathway in cardiac myocytes. A mechanism for O{sub2}-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 276 (2001) 27605-27612
92. Razeghi P., Young M.E., Abbasi S., et al. Hypoxia in vivo decreases peroxisome proliferator-activated receptor alpha-regulated gene expression in rat heart. Biochem Biophys Res Commun 287 (2001) 5-10
93. Razeghi P., Essop M.F., Huss J.M., et al. Hypoxia-induced switches of myosin heavy chain iso-gene expression in rat heart. Biochem Biophys Res Commun 303 (2003) 1024-1027
94. Tong H., Imahashi K., Steenbergen C., et al. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase-dependent pathway is cardioprotective. Circ Res 90 (2002) 377-379
95. Nishihara M., Miura T., Miki T., et al. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Am J Physiol Heart Circ Physiol 291 (2006) H748-H755
96. Kim S.J., Peppas A., Hong S.K., et al. Persistent stunning induces myocardial hibernation and protection: flow/function and metabolic mechanisms. Circ Res 92 (2003) 1233-1239
97. Dewald O., Sharma S., Adrogue J., et al. Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity. Circulation 112 (2005) 407-415
98. Folmes C.D., Clanachan A.S., and Lopaschuk G.D. Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia. Circ Res 99 (2006) 61-68
99. Kantor P.F., Dyck J.R., and Lopaschuk G.D. Fatty acid oxidation in the reperfused ischemic heart. Am J Med Sci 318 (1999) 3-14
100. Randle P.J., Garland P.B., Hales C.N., et al. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1 (1963) 785-789
101. Marsin A.S., Bertrand L., Rider M.H., et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 10 (2000) 1247-1255
102. Orchard C.H. The role of the sarcoplasmic reticulum in the response of ferret and rat heart muscle to acidosis. J Physiol 384 (1987) 431-449
103. Bak M., and Ingwall J. Acidosis during ischemia promotes adenosine triphosphate resynthesis in post-ischemic rat heart. J Clin Invest 93 (1994) 40-49
104. Sambandam N., Morabito D., Wagg C., et al. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia. Am J Physiol Heart Circ Physiol 290 (2006) H87-H95
105. Fallavollita J.A., Malm B.J., and Canty J.M.J. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 92 (2003) 48-55
106. Taegtmeyer H., McNulty P., and Young M.E. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation 105 (2002) 1727-1733
107. Kliewer S.A., Umesono K., Noonan D.J., et al. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358 (1992) 771-774
108. Motojima K., Passilly P., Peters J.M., et al. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner. J Biol Chem 273 (1998) 16710-16714
109. Gulick T., Cresci S., Caira T., et al. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci U S A 91 (1994) 11012-11016
110. Finck B.N., Lehman J.J., Leone T.C., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109 (2002) 121-130
111. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal 12 (2000) 583-594
112. Schmitz-Peiffer C., Craig D.L., and Biden T.J. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274 (1999) 24202-24210
113. Thompson A.L., and Cooney G.J. Acyl-CoA inhibition of hexokinase in rat and human skeletal muscle is a potential mechanism of lipid-induced insulin resistance. Diabetes 49 (2000) 1761-1765
114. Wu P., Inskeep K., Bowker-Kinley M.M., et al. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48 (1999) 1593-1599
115. Stanley W.C., Lopaschuk G.D., and McCormack J.G. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 34 (1997) 25-33
116. Chen V., Ianuzzo C., Fong B., et al. The effects of acute and chronic diabetes on myocardial metabolism in rats. Diabetes 33 (1984) 1078-1084
117. Depre C., Young M.E., Ying J., et al. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 32 (2000) 985-996
118. Young M.E., Patil S., Ying J., et al. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J 15 (2001) 833-845
119. Zhou Y.T., Grayburn P., Karim A., et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97 (2000) 1784-1789
120. Young M.E., Guthrie P.H., Razeghi P., et al. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes 51 (2002) 2587-2595
121. Sharma S., Adrogue J.V., Golfman L., et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 18 (2004) 1692-1700
122. Itani S.I., Zhou Q., Pories W.J., et al. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 49 (2000) 1353-1358
123. Leichman J.G., Aguilar D., King T.M., et al. Association of plasma free fatty acids and left ventricular diastolic function in patients with clinically severe obesity. Am J Clin Nutr 84 (2006) 336-341
124. Rossetti L., Smith D., Shulman G.I., et al. Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. J Clin Invest 79 (1987) 1510-1515
125. Roduit R., Morin J., Masse F., et al. Glucose down-regulates the expression of the peroxisome proliferator-activated receptor-alpha gene in the pancreatic beta-cell. J Biol Chem 275 (2000) 35799-35806
126. Gulick J., Subramaniam A., Neumann J., et al. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 266 (1991) 9180-9185
127. Ojamaa K., Samarel A.M., and Klein I. Identification of a contractile-responsive element in the cardiac alpha-myosin heavy chain gene. J Biol Chem 270 (1995) 31276-31281
128. Golfman L.S., Wilson C.R., Sharma S., et al. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats. Am J Physiol Endocrinol Metab 289 (2005) E328-E336
129. Sack M.N., Rader T.A., Park S., et al. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 94 (1996) 2837-2842
130. Davila-Roman V.G., Vedala G., Herrero P., et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 40 (2002) 271-277
131. Blain J.M., Schafer H., Siegel A.L., et al. Studies on myocardial metabolism. VI. Myocardial metabolism in congestive failure. Am J Med 20 (1956) 820-833
132. Nemoto S., Razeghi P., Ishiyama M., et al. PPAR-gamma agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation. Am J Physiol Heart Circ Physiol 288 (2005) H77-H82